Skip to main content

IDEX Value Stock - Dividend - Research Selection

Idex

ISIN: US45167R1041 , WKN: 877444

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEX Corporation, together with its subsidiaries, operates as an applied solutions company worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment provides precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction, and drying systems for use in beverage, food processing, pharmaceutical, and cosmetics; pneumatic components and sealing solutions, such as pumping solutions for analytical instrumentation, clinical diagnostics, and drug discovery; molded and extruded sealing components; custom mechanical and shaft seals; engineered hygienic mixers and valves; biocompatible medical devices and implantables; and air compressors. This segment also offers optical components and coatings for applications in the scientific research, defense, biotechnology, aerospace, telecommunications, and electronics manufacturing applications; laboratory and commercial equipment to produce micro and nano scale materials; precision photonic solutions; and precision gear and peristaltic pump technologies. The FSDP segment produces and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. The company was incorporated in 1987 and is headquartered in Northbrook, Illinois.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Sohn & Co. Raises Bet on IDEX Corporation (IEX)

2025-09-10
IDEX Corporation (NYSE:IEX) is among the undervalued wide moat stocks to buy now. Metzler seel. Sohn & Co. AG boosted its position in IDEX Corporation (NYSE:IEX) by 69.2% with the purchase of 2,548 shares during the quarter. With holdings worth $1,127,000, the bank owns 6,228 shares of the company’s stock. Two things the company is […]

IDEX: Precision-Driven Growth in a World of Complex Flow Systems

2025-09-07
IDEX delivers quiet excellence through niche leadership, efficient capital use, and strong free cash flow in a high-quality industrial portfolio.

IDEX Corporation (NYSE:IEX) Shares Could Be 32% Below Their Intrinsic Value Estimate

2025-09-06
Key Insights IDEX's estimated fair value is US$241 based on 2 Stage Free Cash Flow to Equity IDEX's US$165 share price...

Why Is Idex (IEX) Up 1.1% Since Last Earnings Report?

2025-08-29
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Reasons Why You Should Avoid Betting on IDEX Stock Right Now

2025-08-27
IEX struggles with weakness in its FMT segment, rising costs and forex headwinds, lowering its stock over the past year.

IDEX Corp Stock: Is Wall Street Bullish or Bearish?

2025-08-27
With IDEX Corp lagging behind the broader market, are analysts bullish or bearish on the stock?

IDEX: A Wonderful Business Finally Trading At A Real Undervaluation

2025-08-25
IDEX stands out as a resilient, wide-moat industrial with strong cash flow, M&A strategy, and improved valuation supporting long-term upside. See why IEX stock is a buy.

Could The Market Be Wrong About IDEX Corporation (NYSE:IEX) Given Its Attractive Financial Prospects?

2025-08-20
It is hard to get excited after looking at IDEX's (NYSE:IEX) recent performance, when its stock has declined 9.5% over...

Why IDEX (IEX) Stock Is Up Today

2025-08-12
Shares of manufacturing company IDEX (NYSE:IEX) jumped 3.6% in the afternoon session after the industrials sector rallied on renewed optimism for a potential Federal Reserve interest rate cut and an agreement to extend the U.S.-China tariff truce. The positive sentiment stems from a recent tame inflation report, which boosts the likelihood of lower borrowing costs—a key stimulant for economic activity that benefits cyclical sectors like industrial products. This optimism was amplified by an agre

IEX Q2 Deep Dive: Cautious Guidance and Delayed Orders Pressure Outlook

2025-08-12
Manufacturing company IDEX (NYSE:IEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.2% year on year to $865.4 million. On the other hand, next quarter’s revenue guidance of $818.2 million was less impressive, coming in 5.6% below analysts’ estimates. Its non-GAAP profit of $2.07 per share was 4% above analysts’ consensus estimates.